BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin FC, Lee SS, Li YC, Ho YC, Chen WY, Chen CJ, Lee MW, Yeh KL, Tsai SC, Kuan YH. Protective Effects of Kirenol against Lipopolysaccharide-Induced Acute Lung Injury through the Modulation of the Proinflammatory NFκB Pathway and the AMPK2-/Nrf2-Mediated HO-1/AOE Pathway. Antioxidants (Basel) 2021;10:204. [PMID: 33572510 DOI: 10.3390/antiox10020204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee CY, Chen SP, Huang-Liu R, Gau SY, Li YC, Chen CJ, Chen WY, Wu CN, Kuan YH. Fucoxanthin decreases lipopolysaccharide-induced acute lung injury through the inhibition of RhoA activation and the NF-κB pathway. Environ Toxicol 2022. [PMID: 35616142 DOI: 10.1002/tox.23587] [Reference Citation Analysis]
2 Xu L, Tu Y, Li J, Zhang W, Wang Z, Zhuang C, Xue L. Structure-based optimizations of a necroptosis inhibitor (SZM594) as novel protective agents of acute lung injury. Chinese Chemical Letters 2022;33:2545-9. [DOI: 10.1016/j.cclet.2021.09.059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ibrahim SRM, Altyar AE, Sindi IA, El-Agamy DS, Abdallah HM, Mohamed SGA, Mohamed GA. Kirenol: A promising bioactive metabolite from siegesbeckia species: A detailed review. J Ethnopharmacol 2021;281:114552. [PMID: 34438028 DOI: 10.1016/j.jep.2021.114552] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tsai PK, Chen SP, Huang-Liu R, Chen CJ, Chen WY, Ng YY, Kuan YH. Proinflammatory Responses of 1-Nitropyrene against RAW264.7 Macrophages through Akt Phosphorylation and NF-κB Pathways. Toxics 2021;9:276. [PMID: 34822668 DOI: 10.3390/toxics9110276] [Reference Citation Analysis]
5 Nasir NN, Sekar M, Fuloria S, Gan SH, Rani NNIM, Ravi S, Begum MY, Chidambaram K, Sathasivam KV, Jeyabalan S, Dhiravidamani A, Thangavelu L, Lum PT, Subramaniyan V, Wu YS, Azad AK, Fuloria NK. Kirenol: A Potential Natural Lead Molecule for a New Drug Design, Development, and Therapy for Inflammation. Molecules 2022;27:734. [PMID: 35163999 DOI: 10.3390/molecules27030734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang C, Wang X, Wang C, He C, Ma Q, Li J, Wang W, Xu YT, Wang T. Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation. Front Pharmacol 2021;12:790072. [PMID: 35002723 DOI: 10.3389/fphar.2021.790072] [Reference Citation Analysis]